Co-Diagnostics (CODX) Misses Q3 EPS by 10c

Co-Diagnostics (NASDAQ: CODX) reported Q3 EPS of ($0.04), $0.10 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $5.1 million versus the consensus estimate of $15.33 million.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating
• AeroVironment restates quarterly financials, citing $89M goodwill error